The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer
about
Confronting the Care Delivery Challenges Arising from Precision MedicineErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials.Breast cancers with EGFR and HER2 co-amplification favor distant metastasis and poor clinical outcome.HER2 expression patterns in paired primary and metastatic endometrial cancer lesions.Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
P2860
The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer
@ast
The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer
@en
type
label
The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer
@ast
The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer
@en
prefLabel
The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer
@ast
The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer
@en
P2093
P2860
P1433
P1476
The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer
@en
P2093
Bo R Rueda
Elisabeth J Diver
Rosemary Foster
Whitfield B Growdon
P2860
P304
P356
10.1634/THEONCOLOGIST.2015-0149
P577
2015-06-22T00:00:00Z